Table 2.
Preprocedural and postprocedural echocardiography data, Intraprocedural information
| Patient no. 1 | Patient no. 2 | Patient no. 3 | |
|---|---|---|---|
| TTE/TEE before 2nd procedure | |||
| LVEF (%) | 60 | 50 | 30 |
| Gradient max/mean (mm Hg) | 18/9 | 24/12 | 15/12 |
| EOA (cm2) | 1.7 | 2.2 | 2.3 |
| Valve insufficiency | severe | moderate-severe | severe |
| ViV procedure | Edwards Sapien XT | JenaValve | CoreValve |
| Edwards Sapien 3 size (mm) | 26 | 29 | 29 |
| Procedure time (mm) | 95 | 100 | 180 |
| Fluoroscopy time (min) | 10 | 11 | 20 |
| Contrast agent (mL) | 121 | 125 | 174 |
| TTE discharge | |||
| LVEF (%) | 60 | 50 | 30 |
| EOA (cm2) | 1.5 | 2.5 | 2.5 |
| Gradient max/mean (mm Hg) | 36/16 | 17/9 | 14/6 |
| Paravalvular leakage | none | trace | trace |
| ICU stay (d) | 2 | 1 | 1 |
| Hospital stay (d) | 10 | 8 | 20 |
| VARC-2 events at 30 days | Major bleeding | None | TIA |
TTE transthoracic echocardiography; TEE transesophageal echocardiography; LVEF left ventricular ejection fraction; ViV valve-in-valve; mm millimeter; min minutes; mL milliliter; EOA effective orifice area; ICU intensive care unit; VARC-2 Valve academic research consortium; TIA transitory ischemic attack; SD standard deviation